GLOW GHK-Cu (50mg) / BPC-157 (10mg) / TB500 (10mg)

A three-component co-formulation supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.

Composition

• GHK-Cu
• BPC-157
• TB-500 (Thymosin Beta 4)
• Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems
• Assay development, including chromatographic separation of three co-formulated peptides
• Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions
• Method documentation for HPLC/LC-MS identity and purity assessments

For qualified research professionals and institutional laboratories. Not for human use.

Documentation & Quality Assurance

Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control. We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process. These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.

Important Notice

This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.

Quality & Manufacturing

All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.

We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.

All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.

What It Is

GLOW Blend is a multi-component research peptide formulation combining three distinct bioactive molecules: GHK-Cu, a copper-coordinated human tripeptide (glycyl-L-histidyl-L-lysine) in which the Cu(II) ion is coordinated by the imidazole nitrogen of histidine, the alpha-amino nitrogen of glycine, and a deprotonated amide nitrogen; BPC-157, a synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, MW 1419.55 Da) corresponding to a partial sequence of a protein from gastric juice; and TB-500, a preparation identified to contain Ac-LKKTETQ, the N-terminal acetylated 17-23 fragment of the 43 amino acid G-actin-sequestering polypeptide thymosin beta-4.

Research Background

GHK-Cu has been investigated across in vitro systems (human dermal fibroblasts, lung fibroblasts from COPD patients, multiple cancer cell lines, keratinocyte cultures), animal models (rats, rabbits, mice, pigs, and dogs), and a limited number of placebo-controlled human skin studies examining photoaging endpoints. BPC-157 has been studied predominantly in rodent preclinical models — including Sprague-Dawley and Wistar rats, mice, and beagle dogs — evaluating wound, tendon, ligament, bone, and gastrointestinal injury models; human research is limited, and a Phase I trial begun in 2015 was not completed with published results. TB-500, identified as containing the N-terminal acetylated 17-23 fragment of thymosin beta-4 (Ac-LKKTETQ), is studied in the context of thymosin beta-4 research, which has employed human umbilical vein endothelial cells and chick aortic arch models.

Observed Areas of Interest in Research

Investigators have examined GHK-Cu's capacity to modulate the expression of thousands of human genes in database analyses, with reported effects on TGF-beta pathway restoration via integrin beta-1 activation, matrix metalloproteinase and TIMP-1/TIMP-2 regulation, NF-kB suppression, and reduction of TNF-alpha-induced IL-6 secretion in dermal fibroblast cultures. BPC-157 research has focused on its interaction with the nitric oxide system, including stimulation of endothelial nitric oxide synthase (eNOS)-derived NO production, upregulation of VEGFR2 in endothelial cells, activation of ERK1/2 and VEGF signaling cascades, and upregulation of antioxidant enzymes including heme oxygenase-1 (HO-1), NQO-1, and glutathione peroxidase. Research on thymosin beta-4 (the parent molecule of the TB-500 fragment) has focused on a seven-amino-acid actin-binding motif identified as essential for observed endothelial cell migration, adhesion, tubule formation, and aortic ring sprouting responses in cell and tissue models.

Research Notes

Purity verified by third-party laboratory analysis (Certificate of Analysis available on request). Supplied strictly for in-vitro and laboratory research use only. Not for human consumption.

All information above is provided for research and educational reference only and summarizes findings from published scientific literature (predominantly in-vitro and animal models). It does not describe outcomes in humans. This product is not a drug, dietary supplement, or article intended for human or veterinary use.

All products from Blitz Health are manufactured using a lyophilization (freeze-drying) process. This method is designed to maintain product integrity and allows vials to remain stable during shipping for approximately 3–4 months.

Once a vial is reconstituted with bacteriostatic water, it should be stored in the refrigerator to help maintain stability. Under these conditions, reconstituted material is generally considered stable for up to 30 days.

Lyophilization is a dehydration technique in which compounds are frozen and then exposed to low pressure. This causes the water in the vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure. This powder can be kept at room temperature until reconstitution.

Upon receipt, products should be stored away from heat and light. For short-term use, refrigeration at approximately 4°C (39°F) is suitable. For long-term storage (several months to years), vials may be placed in a freezer at approximately -80°C (-112°F). Freezing is the preferred method for preserving product stability over extended periods.

⚠️ Important Notice:
These products are intended for research use only. Not for human consumption.